在心房动中GLP-1受体激活剂和心肌代谢
Jiani Zhong1,2, Hang Chen1,2, Qiming Liu1
1Department of Cardiovascular Medicine, Second Xiangya Hospital, Central South University, Changsha, 410011, China.
Journal of pharmaceutical analysis
|May 27, 2024
概括
类似葡萄糖-1受体激动剂 (GLP-1RAs) 可能改善心脏细胞代谢,降低心房 (AF) 风险,特别是在糖尿病和肥胖患者中. 需要进一步的研究来确认临床益处.
科学领域:
- 心脏病学 心脏病学
- 代谢医学是一种代谢医学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 心房动 (AF) 是一种普遍的心律失常,与高血压,糖尿病和肥胖等代谢状况有关.
- 心肌细胞表现出明显的代谢特征,对ATP产生至关重要,在AF中发生变化.
- 现有的AF风险因素包括心力衰竭 (HF),糖尿病 (T2DM) 和肥胖.
研究的目的:
- 在AF期间审查心肌细胞的代谢变化.
- 探索GLP-1RAs在缓解AF相关代谢变化的潜力.
- 在AF风险因素的背景下,评估GLP-1RAs对心肌代谢的影响.
主要方法:
- 对AF中心肌细胞代谢现有文献的综述.
- 分析GLP-1RA对代谢途径,氧化应激,炎症和线粒体功能已知的影响.
- 对临床试验数据和关于GLP-1RA在AF和相关疾病中的疗效的临床前发现进行了审查.
主要成果:
- 显著的代谢转变发生在受AF影响的心肌细胞中.
- GLP-1RAs表现出性作用,包括减少氧化应激,炎症和改善线粒体功能.
- 虽然AF预防的临床试验结果各不相同,但GLP-1RAs在改善心肌代谢方面表现有前途.
结论:
- GLP-1RAs可能提供一种治疗策略,以改善风险较高的人的心肌代谢AF.
- 使用GLP-1RA向代谢途径可能会降低AF发病率,特别是在T2DM和肥胖患者中.
- 需要进一步的临床研究来巩固GLP-1RAs在AF管理中的作用.
相关概念视频
01:24Glucagon-like Receptor Agonists
318
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
318
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
434
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
434
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
738
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
738
01:26Heart Failure Drugs: Inotropic Agents
570
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
570
01:09GPCRs Regulate Adenylyl Cylase Activity
5.5K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.5K